{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:49:56Z","timestamp":1787496596966,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005663","name":"Council of State and Territorial Epidemiologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008246","name":"Tufts University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005217","name":"National Center for Injury Prevention and Control","doi-asserted-by":"publisher","award":["CDC-RFA-OT18\\u20131804"],"award-info":[{"award-number":["CDC-RFA-OT18\\u20131804"]}],"id":[{"id":"10.13039\/100005217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ypmed.2023.107490","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T03:24:13Z","timestamp":1679455453000},"page":"107490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Methods for jurisdictional vulnerability assessment of opioid-related outcomes"],"prefix":"10.1016","volume":"170","author":[{"given":"Shikhar","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric","family":"Bayly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pustz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Van Handel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailyn","family":"Lingwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ypmed.2023.107490_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12889-020-10103-x","article-title":"Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science","volume":"21","author":"Agley","year":"2021","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107490_bb0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/15360288.2022.2070691","article-title":"Comparing two databases to identify access to buprenorphine treatment for opioid use disorder","volume":"36","author":"Anyanwu","year":"2022","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"10.1016\/j.ypmed.2023.107490_bb0015","author":"Arkansas Department of Human Services"},{"key":"10.1016\/j.ypmed.2023.107490_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fsoc.2021.652672","article-title":"A vulnerability assessment for a future HIV outbreak associated with injection drug use in Illinois, 2017-2018","volume":"6","author":"Bergo","year":"2021","journal-title":"Front. Sociol."},{"issue":"12","key":"10.1016\/j.ypmed.2023.107490_bb0025","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/pds.1833","article-title":"Trends in long-term opioid therapy for chronic non-cancer pain","volume":"18","author":"Boudreau","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ypmed.2023.107490_bb0030","author":"Bureau of Epidemiology Pennsylvania Department of Health"},{"key":"10.1016\/j.ypmed.2023.107490_bb0035","author":"CDC"},{"key":"10.1016\/j.ypmed.2023.107490_bb0040","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ypmed.2023.107490_bb0045","series-title":"Data from: Behavioral Risk Factor Surveillance System Survey Data","author":"Centers for Disease Control and Prevention (CDC)","year":"2022"},{"key":"10.1016\/j.ypmed.2023.107490_bb0050","series-title":"Data from: Youth Risk Behavior Survey Data","author":"Centers for Disease Control and Prevention (CDC)","year":"2022"},{"key":"10.1016\/j.ypmed.2023.107490_bb0055","author":"Centers for Medicare & Medicaid Services (CMS)"},{"key":"10.1016\/j.ypmed.2023.107490_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103555","article-title":"Trends in opioid-related crime incidents and comparison with opioid overdose outcomes in the United States","volume":"101","author":"Chen","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.ypmed.2023.107490_bb0065","first-page":"1","article-title":"Reported crime frequencies: a statistical comparison of state crime reports and the UCR","author":"Comer","year":"2021","journal-title":"Am. J. Crim. Justice"},{"key":"10.1016\/j.ypmed.2023.107490_bb0070","series-title":"REQUEST FOR PROPOSALS: Consultant to Conduct Jurisdiction-Level Opioid Related Vulnerability Assessments","author":"Council of State and Territorial Epidemiologists","year":"2019"},{"issue":"3","key":"10.1016\/j.ypmed.2023.107490_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107490_bb0080","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/soej.12481","article-title":"Prescription drug monitoring programs, opioid abuse, and crime","volume":"87","author":"Dave","year":"2021","journal-title":"South. Econ. J."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107490_bb0085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/10903120600724200","article-title":"National Emergency Medical Services Information System (NEMSIS)","volume":"10","author":"Dawson","year":"2006","journal-title":"Prehosp Emerg Care."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107490_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0887403420911415","article-title":"Opioids, race, and drug enforcement: exploring local relationships between neighborhood context and black\u2013white opioid-related possession arrests","volume":"32","author":"Donnelly","year":"2021","journal-title":"Crim. Justice Policy Rev."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107490_bb0095","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/2153368719877222","article-title":"Revisiting neighborhood context and racial disparities in drug arrests under the opioid epidemic","volume":"12","author":"Donnelly","year":"2022","journal-title":"Race Justice."},{"issue":"11","key":"10.1016\/j.ypmed.2023.107490_bb0100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/M17-3074","article-title":"Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses","volume":"168","author":"Fink","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107490_bb0105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12913-017-2354-5","article-title":"Evaluating the impact of prescription drug monitoring program implementation: a scoping review","volume":"17","author":"Finley","year":"2017","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.ypmed.2023.107490_bb0110","series-title":"Assessment of County Vulnerability to Increases in Injectiond Drug Use-Related Infectious Disease and Opioid Overdose","author":"Georgia Department of Public Health","year":"2018"},{"issue":"26","key":"10.1016\/j.ypmed.2023.107490_bb0115","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006-2015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2023.107490_bb0120","article-title":"Drug overdose deaths in the United States, 1999\u20132020","author":"Hedegaard","year":"2021","journal-title":"NCHS Data Brief, no 428. Hyattsville, MD: National Center for Health Statistics"},{"issue":"1","key":"10.1016\/j.ypmed.2023.107490_bb0125","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1038\/s41598-020-61281-y","article-title":"Epidemiological and geospatial profile of the prescription opioid crisis in Ohio, United States","volume":"10","author":"Hernandez","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107490_bb0130","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology."},{"key":"10.1016\/j.ypmed.2023.107490_bb0135","series-title":"Jurisdiction-level Vulnerability Assessments for Risk of Opioid Overdoses and Rapid Dissemination of HIV and Hepatitis C","author":"Iowa Department of Public Health","year":"2019"},{"issue":"4","key":"10.1016\/j.ypmed.2023.107490_bb0140","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.7028","article-title":"Assessment of community-level vulnerability and access to medications for opioid use disorder","volume":"5","author":"Joudrey","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107490_bb0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11113-019-09566-7","article-title":"Spatial non-stationarity in opioid prescribing rates: evidence from older medicare part D beneficiaries","volume":"40","author":"Kim","year":"2021","journal-title":"Popul. Res. Policy Rev."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107490_bb0150","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.healthplace.2009.06.002","article-title":"An enhanced two-step floating catchment area (E2SFCA) method for measuring spatial accessibility to primary care physicians","volume":"15","author":"Luo","year":"2009","journal-title":"Health Place"},{"key":"10.1016\/j.ypmed.2023.107490_bb0155","author":"Maine Department of Health and Human Services"},{"key":"10.1016\/j.ypmed.2023.107490_bb0160","series-title":"Vulnerability Assessment Report and Jurisdictional Plan: South Carolina","author":"Mercadel","year":"2019"},{"key":"10.1016\/j.ypmed.2023.107490_bb0165","author":"Michigan Dept. of Health and Human Services"},{"key":"10.1016\/j.ypmed.2023.107490_bb0170","author":"Missouri Department of Health and Senior Services"},{"issue":"43","key":"10.1016\/j.ypmed.2023.107490_bb0175","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008","volume":"60","year":"2011","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"8","key":"10.1016\/j.ypmed.2023.107490_bb0180","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2105\/AJPH.2019.305136","article-title":"Using Census data to Understand County-level differences in overall drug mortality and opioid-related mortality by opioid type","volume":"109","author":"Monnat","year":"2019","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ypmed.2023.107490_bb0185","series-title":"The Culture of Pain","author":"Morris","year":"1991"},{"key":"10.1016\/j.ypmed.2023.107490_bb0190","series-title":"Wide-Ranging Online Data for Epidemiologic Research (WONDER)","author":"National Center for Health Statistics","year":"2022"},{"key":"10.1016\/j.ypmed.2023.107490_bb0195","series-title":"Comorbidity: Substance Use Disorders and Other Mental Illnesses DrugFacts","author":"National Institute on Drug Abuse","year":"2020"},{"key":"10.1016\/j.ypmed.2023.107490_bb0200","series-title":"Nevada Vulnerability Assessment","author":"Nevada Department of Health and Human Services","year":"2020"},{"issue":"34","key":"10.1016\/j.ypmed.2023.107490_bb0205","doi-asserted-by":"crossref","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","article-title":"Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by Census region - United States, 2006-2015","volume":"66","author":"O\u2019Donnell","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"5","key":"10.1016\/j.ypmed.2023.107490_bb0210","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/add.15768","article-title":"Using death scene and toxicology evidence to define involvement of heroin, pharmaceutical morphine, illicitly manufactured fentanyl and pharmaceutical fentanyl in opioid overdose deaths, 38 states and the District of Columbia, January 2018\u2013December 2019","volume":"117","author":"O\u2019Donnell","year":"2022","journal-title":"Addiction."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107490_bb0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1068\/a160017","article-title":"Ecological fallacies and the analysis of areal census data","volume":"16","author":"Openshaw","year":"1984","journal-title":"Environ. Plan. A"},{"issue":"19","key":"10.1016\/j.ypmed.2023.107490_bb0220","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/jama.279.19.1521","article-title":"Emerging ethical issues in palliative care","volume":"279","author":"Pellegrino","year":"1998","journal-title":"Jama."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107490_bb0225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005650-198102000-00001","article-title":"The concept of access: definition and relationship to consumer satisfaction","volume":"19","author":"Penchansky","year":"1981","journal-title":"Med. Care"},{"issue":"2\u20133","key":"10.1016\/j.ypmed.2023.107490_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2307\/165978","article-title":"Congress, international narcotics policy, and the anti\u2013drug abuse act of 1988","volume":"30","author":"Perl","year":"1988","journal-title":"J. Interam. Stud. World Affairs."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107490_bb0235","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11904-018-0390-3","article-title":"The Syndemic of opioid misuse, overdose, HCV, and HIV: structural-level causes and interventions","volume":"15","author":"Perlman","year":"2018","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.ypmed.2023.107490_bb0240","first-page":"1478","article-title":"Systematic literature review of prescription drug monitoring programs","volume":"2018","author":"Ponnapalli","year":"2018","journal-title":"AMIA Annu Symp Proc."},{"issue":"11","key":"10.1016\/j.ypmed.2023.107490_bb0245","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/cid\/cix1079","article-title":"Tennessee\u2019s in-state vulnerability assessment for a \u201crapid dissemination of human immunodeficiency virus or hepatitis c virus infection\u201d event utilizing data about the opioid epidemic","volume":"66","author":"Rickles","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ypmed.2023.107490_bb0250","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid Abuse\/dependence and associated serious infections increased sharply, 2002-12","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)."},{"key":"10.1016\/j.ypmed.2023.107490_bb0255","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.nut.2011.11.003","article-title":"Prevalence of malnutrition and nutritional risk factors in patients undergoing alcohol and drug treatment","volume":"28","author":"Ross","year":"2012","journal-title":"Nutrition."},{"key":"10.1016\/j.ypmed.2023.107490_bb0260","author":"Rural Opioid Initiative Research Consortium"},{"key":"10.1016\/j.ypmed.2023.107490_bb0265","article-title":"Characterizing opioid-involved overdose risk in local communities: an opioid overdose vulnerability assessment across Indiana, 2017","volume":"24","author":"Sawyer","year":"2021","journal-title":"Prev. Med. Rep."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107490_bb0270","first-page":"46","article-title":"Mapping the opioid epidemic in Rhode Island: where are we missing resources?","volume":"103","author":"Schneider","year":"2020","journal-title":"R I Med J (2013)"},{"key":"10.1016\/j.ypmed.2023.107490_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106040","article-title":"A vulnerability assessment for the HCV infections associated with injection drug use","volume":"134","author":"Sharareh","year":"2020","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2023.107490_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2020.113352","article-title":"Spatial epidemiology: an empirical framework for syndemics research","volume":"295","author":"Shrestha","year":"2022","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.ypmed.2023.107490_bb0285","article-title":"Examining the spatial risk environment tied to the opioid crisis through a unique public health, EMS, and academic research collaborative: Lowell, Massachusetts, 2008\u20132018","volume":"24","author":"Stopka","year":"2021","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.ypmed.2023.107490_bb0290","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.ypmed.2023.107490_bb0295","author":"Substance Abuse and Mental Health Services Administration Treatment"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107490_bb0300","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.pain.2008.04.027","article-title":"Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study","volume":"138","author":"Sullivan","year":"2008","journal-title":"Pain."},{"issue":"14","key":"10.1016\/j.ypmed.2023.107490_bb0305","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1080\/10826084.2017.1376685","article-title":"The curious (dis)connection between the opioid epidemic and crime","volume":"52","author":"Szalavitz","year":"2017","journal-title":"Subst. Use Misuse"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107490_bb0310","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/11597520-000000000-00000","article-title":"Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals","volume":"72","author":"Tetrault","year":"2012","journal-title":"Drugs."},{"key":"10.1016\/j.ypmed.2023.107490_bb0315","series-title":"Data from: American Community Survey. Washington, D.C","author":"U.S. Census Bureau","year":"2022"},{"issue":"3","key":"10.1016\/j.ypmed.2023.107490_bb0320","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","article-title":"County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States","volume":"73","author":"Van Handel","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107490_bb0325","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am. J. Public Health"},{"issue":"4","key":"10.1016\/j.ypmed.2023.107490_bb0330","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11481-011-9296-1","article-title":"Opioids and HIV\/HCV infection","volume":"6","author":"Wang","year":"2011","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.ypmed.2023.107490_bb0335","author":"Washington State Department of Health"},{"issue":"Supplement_5","key":"10.1016\/j.ypmed.2023.107490_bb0340","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.1093\/infdis\/jiaa231","article-title":"Assessing county-level vulnerability for opioid overdose and rapid spread of human immunodeficiency virus and hepatitis C infection in South Dakota","volume":"222","author":"Wesner","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2023.107490_bb0345","author":"West Virginia Department to Health and Human Services"},{"issue":"3","key":"10.1016\/j.ypmed.2023.107490_bb0350","doi-asserted-by":"crossref","first-page":"e180558","DOI":"10.1001\/jamanetworkopen.2018.0558","article-title":"Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ypmed.2023.107490_bb0355","author":"Wisconsin Department of Health Services"},{"issue":"17","key":"10.1016\/j.ypmed.2023.107490_bb0360","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 years - Kentucky, Tennessee, Virginia, And West Virginia, 2006\u20132012","volume":"64","author":"Zibbell","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly Rep."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743523000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743523000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:54:13Z","timestamp":1778702053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743523000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":72,"alternative-id":["S0091743523000701"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2023.107490","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methods for jurisdictional vulnerability assessment of opioid-related outcomes","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2023.107490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107490"}}